Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000148543 | SCV000050828 | benign | Long QT syndrome | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000154657 | SCV000204333 | likely benign | not specified | 2017-07-20 | criteria provided, single submitter | clinical testing | p.Lys393Asn in exon 9 of KCNQ1: This variant is not expected to have clinical si gnificance because it has been reported in the literature in both control and cl inical cohorts (Ackerman 2003, Moss 2007, Guidicessi 2012, Crotti 2013). In addi tion, this variant has been identified in 0.3% (27/10152) of Ashkenazi Jewish ch romosomes and 0.2% (52/30782) of South Asian chromosomes including 1 homozygote by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; db SNP rs12720457). Studies have shown that the p.Lys393Asn variant does not impact protein function (Shamgar 2006). Furthermore, the lysine (Lys) at amino acid po sition 393 is not conserved across species, including mammals. Of note, cat has an asparagine (Asn) at this position despite high nearby amino acid conservation . Additional computational analyses do not suggest a high likelihood of impact t o the protein. In summary, this variant is classified as likely benign based on the available data. |
Eurofins Ntd Llc |
RCV000057570 | SCV000232929 | uncertain significance | not provided | 2015-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000057570 | SCV000234375 | likely benign | not provided | 2021-03-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19862833, 25637381, 22949429, 23861362, 31337358, 16556865, 24400285, 23571586, 14661677, 17161064, 14678125, 17210839, 17470695, 19841300, 23396983, 24055113, 25854863, 28074886, 22677073, 30020974, 26970180, 29431662) |
Illumina Laboratory Services, |
RCV000394039 | SCV000370275 | likely benign | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000306809 | SCV000370276 | likely benign | Jervell and Lange-Nielsen syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001094051 | SCV000370277 | likely benign | Long QT syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000394030 | SCV000370278 | likely benign | Short QT syndrome type 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000305127 | SCV000370279 | likely benign | Atrial fibrillation, familial, 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV000148543 | SCV000555803 | benign | Long QT syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000057570 | SCV000604064 | likely benign | not provided | 2023-09-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841659 | SCV000911310 | likely benign | Cardiac arrhythmia | 2018-03-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154657 | SCV000919556 | likely benign | not specified | 2017-10-16 | criteria provided, single submitter | clinical testing | Variant summary: The KCNQ1 c.1179G>T (p.Lys393Asn) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 292/277174 control chromosomes, including 1 homozygous individual, predominantly observed in the Ashkenazi Jewish subpopulation at a frequency of 0.00266 (27/10152). This frequency is about 27 times the estimated maximal expected allele frequency of a pathogenic KCNQ1 variant (0.0001), suggesting this is likely a benign polymorphism found primarily in the populations of Ashkenazi Jewish origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign. Taken together, this variant is classified as likely benign. |
Center for Advanced Laboratory Medicine, |
RCV000852645 | SCV000995350 | benign | Cardiomyopathy | 2017-08-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000057570 | SCV001148156 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | KCNQ1: BS2 |
Institute of Human Genetics, |
RCV001094051 | SCV001440824 | likely benign | Long QT syndrome 1 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336208 | SCV002637437 | likely benign | Cardiovascular phenotype | 2018-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Dept of Medical Biology, |
RCV000148543 | SCV004022028 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: BS1 |
Cardiovascular Biomedical Research Unit, |
RCV000057570 | SCV000089089 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:14661677;PMID:14678125;PMID:17161064;PMID:17210839;PMID:17470695;PMID:19841300;PMID:19862833). | |
CSER _CC_NCGL, |
RCV000148543 | SCV000190256 | likely benign | Long QT syndrome | 2014-06-01 | no assertion criteria provided | research | |
Laboratory of Diagnostic Genome Analysis, |
RCV000057570 | SCV001799905 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000057570 | SCV001926148 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000057570 | SCV001953903 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000057570 | SCV001974927 | likely benign | not provided | no assertion criteria provided | clinical testing |